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Introduction   
   
Reconstructive dental surgeons are constantly looking for an “edge” that jump starts 
the healing process to maximize predictability as well as the volume of regenerated 
bone. Is it bone morphogenetic protein-2 (BMP-2), recombinant platelet derived 
growth factor-BB (rhPDGF-BB), platelet rich plasma (PRP), plasma rich in growth 
factors (PRGF), or a combination of all? The question serves to introduce a second 
generation platelet concentrate, platelet-rich fibrin (PRF).  
                       PRF is easy to obtain, less costly, and a possibly very beneficial 
ingredient to add to the “regenerative mix.” Regardless of the choice of graft material 
(autograft, allograft, xenograft or alloplast) or membrane selection (bioresorbable or 
nonresorbable), predictable bone regeneration is dependent upon 4 major biologic 
principles: primary wound closure, blood supply, space maintenance, and wound 
stability. [1]Blood supply provides the necessary cells, growth factors, and inhibitors to 
initiate the osteogenic biomineralization cascade. [2]  
                   Injury to blood vessels during oral surgical procedures causes blood 
extravasation, subsequent platelet aggregation, and fibrin clot formation. The major 
role of fibrin in wound repair is hemostasis, but fibrin also provides a matrix for the 
migration of fibroblasts and endothelial cells that are involved in angiogenesis and 
responsible for remodeling of new tissue. Platelet activation in response to tissue 
damage and vascular exposure results in the formation of a platelet plug and blood 
clot as well as the secretion of biologically active protein. [3] Platelet-rich fibrin (PRF) 
represents a new step in the platelet gel therapeutic concept with simplified 
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Abstract      
                         
Aims & objectives: The motto behind any periodontal treatment is arrest of periodontal 
disease and regeneration of lost periodontium. Various treatment strategies have been 
employed in treatment of intrabony defects, but the best way to obtain regeneration is 
probably by mimicking the actual occurring events that takes place in the formation of the 
periodontal tissues at embryonic stage. Conventional open flap debridement falls short of 
regenerating tissues destroyed by the disease and current regenerative procedures offer a 
limited potential towards attaining complete periodontal regeneration.  Platelet rich fibrin 
(PRF), a second generation platelet concentrate is widely used in osseous regeneration.  
Case description: The present study aimed to explore the clinical and radiographical 
effectiveness of autologous PRF along with the osseomold bone graft in treatment of 2 
different cases of intrabony defects in chronic periodontitis subjects. 
Conclusion: Among the 2 subjects, case-1 had 2-wall defect and case-2 patient had 3-wall 
defect. Both the subjects reported to the department with a complaint of food impaction 
and with clinically accessible >7-8mm pocket.  Pocket depth was assessed at 3 months, 
6months and 9months respectively and radio graphically bone gain was accessed at 3 
month and 6 months. 
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responsible for remodeling of new tissue. Platelet 
activation in response to tissue damage and vascular 
exposure results in the formation of a platelet plug and 
blood clot as well as the secretion of biologically active 
protein. [3] Platelet-rich fibrin (PRF) represents a new 
step in the platelet gel therapeutic concept with 
simplified processing minus artificial biochemical 
modification. [4] Unlike other platelet concentrates, [5-8] 
this technique requires neither anticoagulants nor bovine 
thrombin (nor any other gelifying agent), making it no 
more than centrifuged natural blood without additives.  
                  Developed in France by Choukroun et al in 
2001, [9] the PRF production protocol attempts to 
accumulate platelets and released cytokines in a fibrin 
clot. Though platelets and leukocyte cytokines play an 
important part in the biology of this biomaterial, the 
fibrin matrix supporting them certainly constitutes the 
determining element responsible for the real therapeutic 
potential of PRF. [10-11] 
                 PRF is in the form of a platelet gel and can be 
used in conjunction with bone grafts, which offers 
several advantages including promoting wound healing, 
bone growth and maturation, graft stabilization, wound 
sealing and hemostasis, and improving the handling 
properties of graft materials. PRF can also be used as a 
membrane. Clinical trials suggest that the combination 
of bone grafts and growth factors contained in PRP and 
PRF may be suitable to enhance bone density. 
               With the support of literature in hand, the 
present modality for treating intrabony defects using the 
combination of bone graft and autologous PRF was 
carried out to see its effectiveness clinically and 
radiographically through the follow up data till 9 months.  
 
Case Reports 
 
Case 1:  A 28-year-old female complaining of food 
lodgement and pain in the upper right maxillary region 
reported to the Department of Periodontics, PMNM 
Dental College and Hospital, Bagalkot, Karnataka, India. 
There was neither reported history of dental trauma, 
orthodontic treatment nor any adverse habits. Intraoral 
examination revealed generalized bleeding on probing 
with no noticeable swelling or pus exudation. The 
probing pocket depth (PPD) on distobuccal aspect of 
tooth #26 was 9mm with the periodontal attachment 
level (PAL) of 8mm, with negative results for mobility and 
fremitus test, precluding the possibility of trauma from 
occlusion. (Fig 1) A periapical radiograph was taken 
using the standardized techniques, which along with 
clinical evaluation revealed presence of 2 walled 
interproximal intrabony defects (IBD)  (Fig 2) 
 
 
Case 2: A 35-year-old male reported to the same 
institution complaining of pain and food lodgement in 
the lower left posterior region of mandible and mobility 
in relation with the last molar. In case of case 2, PPD on 
the distal aspect of tooth #37 was 8mm and PAL was 
7mm, along with grade III mobile #38, which was 
extracted followed by antibiotic prophylaxis. (Fig 
3)Further examination by periapical radiographs helped 
to appreciate the 3 walled intrabony defect in realation 
to distal aspect of tooth #37. (Fig 4) 
            Both the subjects did not give any relevant 
history of systemic condition which could interfere with 
physiological wound healing. Keeping all the findings in 
the mind, a thorough treatment plan was decided, 
including a series of therapeutic procedures, 
1. Oral hygiene instructions, education & motivation 
regarding the oral hygiene maintenance. 
2. Non-surgical periodontal therapy after a period of 2 
weeks by means of conventional scaling and root 
planing, using curettes and ultrasonic instruments. 
3. Recall after every week and re-examination of the 
patient after the completion of healing after 6 weeks 
following non-surgical periodontal therapy. PPD and PAL 
were measured every week for six weeks after the non 
surgical periodontal therapy and they were still found to 
be 8 mm and 7 mm respectively in case 1 subject but 
PPD & PAL was reduced by 1mm in case 2 subject. 
4. Surgical periodontal therapy was done 2 weeks after 
the re-examination of the patient after completion of 
healing following non-surgical periodontal therapy.  
Both the subjects, complete blood examination was 
assessed and values were before planning for the 
periodontal surgical procedure.  
 
PRF preparation: 
The PRF was prepared in accordance with the protocol 
developed by Choukroun et al. [9] just prior to surgery; 
the required quantity of intravenous blood was drawn & 
collected into 10ml sterile test tubes without an 
anticoagulant and centrifuged immediately for 12 min at 
2700 rpm. The resultant product consisted of following 3 
layers- topmost layer consisted of acellular platelet poor 
plasma (PPP), PRF clot in the middle and RBC’s at the 
bottom.  PRF was easily separated from red corpuscles 
base [preserving a small red blood cell (RBC) layer] using 
a sterile tweezers and scissors just after removal of PRF 
and then transferred onto a sterile dapen dish. (Fig 5) 
Surgical procedure: 
Intra-oral antisepsis was performed with 0.2% 
chlorhexidine digluconate rinse and Iodine solution was 
used to carry out extraoral antisepsis. Following 
administration of local anaesthesia, sulcular incisions 
were made and mucoperiosteal flaps were reflected. (Fig 
6). Meticulous defect debridement and root planing 
were carried out. PRF of the required size mixed with 
osseomold was filled into the intrabony defect. (Fig 7) 
The mucoperiosteal flaps were repositioned and sutured 
followed by periodontal dressing. 
 
Postoperative Care: 
                The Suitable antibiotics and analgesics 
(amoxicillin 500 mg four times per day for 5 days and 
ibuprofen 800 mg three times per day) were prescribed,  
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Fig 1. Case 1: pre-operative probing depth 
Fig 3. Case 2: pre-operative probing depth 
Fig 2. Case 1: IOPA showing the bone loss 
Fig 4. Case 2: IOPA showing the bone loss 
Fig 5. Preparation of PRF & Bone graft mixture 
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Fig 8,9 - IOPA showing bone fill after 9 months 
Fig 7. Placement of PRF & Bone graft 
Fig 6. After flap reflection 
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along with chlorhexidine digluconate rinses (0.2%) twice 
daily for 2 weeks. Periodontal dressing and sutures were 
removed 2 weeks post-operatively. Surgical wounds 
were gently cleansed with 0.2% of chlorhexidine 
digluconate and patient was instructed for gentle 
brushing with a soft toothbrush. Patient was re-
instructed for proper oral hygiene measures 
postoperatively and examined weekly up to 1 month 
after surgery and then 6 and 9 months. No subgingival 
instrumentation was attempted at any of these 
appointments. Re-examination at 9 months after the 
periodontal surgery revealed reduction in PPD (from 9 
mm to 6 mm) and PAL (from 8 mm to 5 mm) in case 
1(Fig 8) and  in case 2 PPD (8mm to 5mm) and PAL 
(7mm-4mm) (Fig 9) respectively, with appreciable 
radiographic bone formation in the periodontal 
intrabony defect.  
 
DISCUSSION 
 
The present case reports have shown the clinical efficacy 
of PRF and OSSEOMOLD in the treatment of IBD 
suggesting a significant reduction in PPD and PAL gain. 
Radiographically, significant radiographic bone 
formation in the intrabony defect, supporting the role of 
various growth factors present in the PRF in accelerating 
the soft and hard tissue healing was appreciated. 
Presence of a 3-wall IBD  provided the best spatial 
relationship for defect bridging by vascular and cellular 
elements from the periodontal ligament and adjacent 
osseous wall.[12] Space maintenance is provided by the 
defect walls to minimize membrane collapse and/ or 
provides protection and retention of the grafts.[12] 
Osteoblasts cultured with PRF showed a intiation in 
mineralization process by using light and scanning 
electron microscopy and PRF leucocytes shown 
proliferation and interaction with osteoblasts.  
Preparation of PRF is quite easy,  fast and simplified 
processing without any additional artificial biochemical 
modifiers as in PRP, which takes more time. [13] The PRF 
preparation process creates a gel like fibrin matrix 
polymerized in a tetramolecular structure that 
incorporates platelets, leukocyte, and cytokines, and 
circulating stem cells. [14] PRF would be able to 
progressively release cytokines during fibrin matrix 
remodeling; such a mechanism might explain the 
clinically observed healing properties of PRF. [15] It is 
also found that PRF organized as a dense fibrin scaffold 
with a high number of leukocytes concentrated in one 
part of the clot, [16] with a specific slow release of 
growth factors (such as transforming growth factor-1β, 
PDGF, and vascular endothelial growth factor) and 
glycoproteins (such as thrombospondin-1) during ≥7 
days. [17]  Simplified, easy, fast and cost effective 
processing of PRF preparation without use of any 
anticoagulant, along with functional, intact platelet in 
fibrin matrix and sustained release of growth factors, all 
these help to make PRF first in fibrin technology. [15] 
 
 
CONCLUSIONS 
 
In the present case reports, clinical and radiographic 
findings reveal the amount of bone formation achieved 
with the combination of Osseomold +PRF in the 
treatment of a periodontal intrabony defects. PRF is an 
autologous preparation and found to be clinically 
effective and economical than any other available 
regenerative materials including PRP. However, long 
term, multicenter randomized, controlled clinical trial will 
be required to know its clinical and radiographic effect 
over bone regeneration. 
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